GRI

SEC source: 0001104659-21-068838 · tm2116776-6_4.xml · derivative · entry 1

Ammer Richard · CIK 0001843671 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2031-05-14

F1 · derivative.exercise_date: The stock option vests in 24 equal monthly installments such that the stock option is fully vested on the second annual anniversary of the date of grant.

SEC source: 0001104659-21-068837 · tm2116776-5_4.xml · derivative · entry 2

Levi Ofir · CIK 0001843598 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2031-05-14

F2 · derivative.exercise_date: The stock option vests in 24 equal monthly installments such that the stock option is fully vested on the second annual anniversary of the date of grant.

SEC source: 0001104659-21-068837 · tm2116776-5_4.xml · derivative · entry 1

Levi Ofir · CIK 0001843598 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2031-05-14

F1 · derivative.exercise_date: The stock option vests as to 50% of the underlying shares of common stock on June 30, 2021, then in two equal installments on September 30, 2021 and December 31, 2021, such that the stock option fully vests on December 31, 2021.

SEC source: 0001104659-21-068831 · tm2116776-3_4.xml · derivative · entry 1

Toren Penny · CIK 0001843596 · SVP, Regul Affairs & Prog Mgmt

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2031-05-14

F1 · derivative.exercise_date: Vests as to 25% of the underlying shares of common stock on the first annual anniversary of the date of grant, then in 12 equal quarterly installments such that the stock option is fully vested on the fourth annual anniversary of the date of grant.

SEC source: 0001104659-21-068828 · tm2116776-2_4.xml · derivative · entry 1

Baker David Charles · CIK 0001844060 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

Underlying: Common Stock · 100,000 shares

Expires 2031-05-14

F1 · derivative.exercise_date: Vests as to 25% of the underlying shares of common stock on the first annual anniversary of the date of grant, then in 12 equal quarterly installments such that the stock option is fully vested on the fourth annual anniversary of the date of grant.

SEC source: 0001104659-21-022190 · tm214979-8_4seq1.xml · nonDerivative · entry 1

Ammer Richard · CIK 0001843671 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By SALMON Pharma GmbH

Disclosed balance after: 47,063

F1 · kind: Issued immediately prior to the closing of the initial public offering of the issuer's common stock in connection with the conversion of the promissory notes held by the reporting person, as disclosed in the prospectus, dated February 9, 2021, filed with the U.S. Securities and Exchange Commission on February 11, 2021, which forms a part of the Registration Statements on Form S-1 (File Nos. 333-249636 and 333-252925), originally filed on October 23, 2020, as amended.

F2 · ownership.direct: The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

SEC source: 0001104659-21-022188 · tm214979-10_4seq1.xml · nonDerivative · entry 1

SALMON Pharma GmbH · CIK 0001843677 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,063

F1 · kind: Issued immediately prior to the closing of the initial public offering of the issuer's common stock in connection with the conversion of the promissory notes held by the reporting person, as disclosed in the prospectus, dated February 9, 2021, filed with the U.S. Securities and Exchange Commission on February 11, 2021, which forms a part of the Registration Statements on Form S-1 (File Nos. 333-249636 and 333-252925), originally filed on October 23, 2020, as amended.

SEC source: 0001104659-21-022187 · tm214979d7_4seq1.xml · derivative · entry 1

Thorell Marella · CIK 0001826323 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,000

Underlying: Common Stock · 15,000 shares

Expires 2031-02-12

F1 · derivative.exercise_date: The stock option vests in 24 equal monthly installments such that the stock option shall be fully vested as of the second anniversary of the consummation of the initial public offering of the company's common stock.

SEC source: 0001104659-21-022185 · tm214979-9_4seq1.xml · nonDerivative · entry 2

Baker David Charles · CIK 0001844060 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,843

SEC source: 0001104659-21-022185 · tm214979-9_4seq1.xml · nonDerivative · entry 1

Baker David Charles · CIK 0001844060 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,843

F1 · kind: Issued immediately prior to the closing of the initial public offering of the issuer's common stock in connection with the conversion of the promissory notes held by the reporting person, as disclosed in the prospectus, dated February 9, 2021, filed with the U.S. Securities and Exchange Commission on February 11, 2021, which forms a part of the Registration Statements on Form S-1 (File Nos. 333-249636 and 333-252925), originally filed on October 23, 2020, as amended.